| Simulated genital samples in transport media with stabilised microorganisms. |
Trichomonas vaginalis
|
Antigen or Molecular |
| Simulated cervical samples with chemically modified, non-infectious virus cells. |
HPV
|
- |
|
HPV genotyping
|
- |
| Simulated nasopharyngeal samples containing inactivated virus in storage buffer |
RSV Antigen
|
- |
|
Influenza A Antigen
|
- |
|
Influenza B Antigen
|
- |
|
Influenza A or B Antigen
|
- |
|
Adenovirus Antigen
|
- |
| Simulated faecal samples containing inactivated rotavirus in storage buffer. |
Rotavirus Antigen
|
- |
| Simulated blood cultures with chemically modified, non-infectious bacterial and fungal cells. |
Acinetobacter sp.
|
- |
|
Acinetobacter baumannii
|
- |
|
Citrobacter sp.
|
- |
|
Enterobacteriaceae
|
- |
|
Enterobacter sp.
|
- |
|
Enterobacter cloacae complex
|
- |
|
Enterococcus sp.
|
- |
|
Enterococcus faecalis
|
- |
|
Enterococcus faecium
|
- |
|
Escherichia coli
|
- |
|
Haemophilus influenzae
|
- |
|
Klebsiella oxytoca
|
- |
|
Klebsiella pneumoniae
|
- |
|
Listeria sp.
|
- |
|
Listeria monocytogenes
|
- |
|
Neisseria meningitidis
|
- |
|
Proteus sp.
|
- |
|
Pseudomonas aeruginosa
|
- |
|
Serratia marcescens
|
- |
|
Staphylococcus sp.
|
- |
|
Staphylococcus aureus
|
- |
|
Staphylococcus epidermidis
|
- |
|
Staphylococcus lugdunensis
|
- |
|
Streptococcus sp
|
- |
|
Streptococcus agalactiae
|
- |
|
Streptococcus anginosus group
|
- |
|
Streptococcus pneumoniae
|
- |
|
Streptococcus pyogenes
|
- |
|
Candida albicans
|
- |
|
Candida glabrata
|
- |
|
Candida krusei
|
- |
|
Candida parapsilosis
|
- |
|
Candida tropicalis
|
- |
|
Resistance Gene: mecA
|
- |
|
Resistance Gene: vanA/B
|
- |
|
Resistance Gene: vanA
|
- |
|
Resistance Gene: vanB
|
- |
|
Resistance Gene: KPC
|
- |
|
Resistance Gene: CTX-M
|
- |
|
Resistance Gene: IMP
|
- |
|
Resistance Gene: NDM
|
- |
|
Resistance Gene: OXA
|
- |
|
Resistance Gene: VIM
|
- |
| Simulated faecal samples with chemically modified, non-infectious bacterial and parasitic cells and intact viral particles |
Campylobacter sp
|
- |
|
C. difficile toxin A/B
|
- |
|
Enteroaggregative E. coli (EAEC)
|
- |
|
Enteropathogenic E. coli (EPEC)
|
- |
|
Enterotoxigenic E. coli (ETEC)lt/st
|
- |
|
E. coli O157
|
- |
|
Plesiomonas shigelloides
|
- |
|
Salmonella
|
- |
|
Shigella
|
- |
|
Shiga-like toxin producing E. coli (STEC) stx1/stx2
|
- |
|
Shigella / Enteroinvasive E. coli (EIEC)
|
- |
|
Shiga Toxin 1
|
- |
|
Shiga Toxin 2
|
- |
|
Vibrio
|
- |
|
Vibrio cholerae
|
- |
|
Yersinia enterocolitica
|
- |
|
Cryptosporidium
|
- |
|
Cyclospora cayetanensis
|
- |
|
Entamoeba histolytica
|
- |
|
Giardia lamblia
|
- |
|
Adenovirus F 40/41
|
- |
|
Astrovirus
|
- |
|
Norovirus GI/GII
|
- |
|
Rotavirus A
|
- |
|
Sapovirus
|
- |
| Simulated CSF with chemically modified, non-infectious bacterial and fungal cells and intact viral particles |
Escherichia coli K1
|
- |
|
Listeria monocytogenes
|
- |
|
Neisseria meningitidis
|
- |
|
Streptococcus agalactiae
|
- |
|
Streptococcus pneumoniae
|
- |
|
Cytomegalovirus
|
- |
|
Enterovirus
|
- |
|
Herpes simplex virus 1
|
- |
|
Herpes simplex virus 2
|
- |
|
Human herpes virus 6
|
- |
|
Human parechovirus
|
- |
|
Varicella zoster virus
|
- |
|
Cryptococcus neoformans/gatti
|
- |
| Simulated nasopharyngeal washings with chemically modified, non-infectious bacterial cells and intact viral particles |
Bordetella holmesii
|
- |
|
Bordetella pertussis
|
- |
|
B. parapertussis/ bronchiseptica
|
- |
|
Chlamydophila pneumoniae
|
- |
|
Mycoplasma pneumoniae
|
- |
|
Adenovirus
|
- |
|
Coronavirus
|
- |
|
Coronavirus 229E
|
- |
|
Coronavirus HKU1
|
- |
|
Coronavirus NL63
|
- |
|
Coronavirus OC43
|
- |
|
Human Metapneumovirus (hMPV)
|
- |
|
Human Rhinovirus / Enterovirus
|
- |
|
Influenza A
|
- |
|
Influenza A H1
|
- |
|
Influenza A H3
|
- |
|
Influenza A / H1-2009
|
- |
|
Influenza B
|
- |
|
Parainfluenza 1,2,3,4
|
- |
|
Respiratory Syncytial Virus
|
- |
|
RSV A,B
|
- |
|
Rhinovirus
|
- |
| Simulated respiratory samples containing chemically modified, non-infectious bacterial cells |
Bordetella pertussis
|
- |
|
Bordetella parapertussis
|
- |
| Simulated faecal samples containing heat inactivated C. difficile |
C. difficile Toxin
|
- |
|
C. difficile Antigen
|
- |
| Simulated genital/urinary samples in specimen transport media containing non-infectious bacterial cells |
Chlamydia trachomatis
|
- |
|
Neisseria gonorrhoeae
|
- |
| Simulated patient cultures from various sources containing lyophilized bacteria on swabs and/or a lyophilized pellet with diluent |
Blood culture ID
|
- |
|
Blood culture susceptibility
|
- |
|
CSF culture ID
|
- |
|
CSF culture susceptibility
|
- |
|
Ear/Eye culture ID
|
- |
|
Group B Strep culture
|
- |
|
N. gonorrhoeae culture
|
- |
|
Sputum culture ID
|
- |
|
Sputum culture susceptibility
|
- |
|
Stool culture ID
|
- |
|
Throat culture ID
|
- |
|
Urine colony count
|
- |
|
Urine culture ID
|
- |
|
Urine culture susceptibility
|
- |
|
Wound culture ID
|
- |
|
Wound culture susceptibility
|
- |
| Virtual images of Gram stained smears from various patient sources |
Gram Stain Interpretation
|
- |
|
Leukocytes
|
- |
|
Stain Quality
|
- |
|
Sputum Specimen Quality
|
- |
| Virtual images of Gram stained patient vaginal smears |
Bacterial vaginosis
|
- |
|
Nugent Score
|
- |
| Simulated genital samples containing lyophilized bacteria on a swab |
Group B Strep culture
|
- |
| Simulated urine samples containing heat inactivated Legionella pneumophila |
Legionella pneumophila Antigen
|
- |
| Simulated patient samples containing lyophilized bacteria on a swab |
Methicillin-Resistant Staphylococcus aureus culture
|
- |
|
Methicillin-Resistant Staphylococcus aureus
|
- |
|
Staphylococcus Aureus
|
- |
| Simulated nasopharyngeal washings with chemically modified, non-infectious bacterial cells. |
Mycoplasma pneumoniae
|
- |
| Simulated urine samples containing heat inactivated Streptococcus pneumoniae |
Streptococcus pneumoniae Antigen
|
- |
| Simulated patient throat swabs containing lyophilized bacteria. |
Group A Strep
|
- |
|
Group C/G Strep
|
- |
|
Vancomycin-Resistant Enterococcus
|
Culture isolation and identification |
| Simulated faecal samples in formalin with stabilised microorganisms. |
Cryptosporidium Antigen
|
- |
|
Giardia Antigen
|
- |
| Simulated Sputum/BAL with chemically modified, non-infectious bacterial and fungal cells and intact viral particles |
Acinetobacter (ACB) complex
|
- |
|
Chlamydia pneumoniae
|
- |
|
Enterobacter cloacae complex
|
- |
|
Escherichia coli
|
- |
|
Haemophilus influenzae
|
- |
|
Klebsiella aerogenes
|
- |
|
Klebsiella oxytoca
|
- |
|
Klebsiella pneumoniae group
|
- |
|
Legionella pneumophila
|
- |
|
Moraxella catarrhalis
|
- |
|
Mycoplasma pneumoniae
|
- |
|
Proteus sp.
|
- |
|
Pseudomonas aeruginosa
|
- |
|
Serratia marcescens
|
- |
|
Staphylococcus aureus
|
- |
|
Streptococcus agalactiae
|
- |
|
Streptococcus pneumoniae
|
- |
|
Streptococcus pyogenes
|
- |
|
Adenovirus
|
- |
|
Coronavirus
|
- |
|
Human Metapneumovirus (hMPV)
|
- |
|
Human Rhinovirus / Enterovirus
|
- |
|
Influenza A
|
- |
|
Influenza B
|
- |
|
Parainfluenza virus
|
- |
|
Respiratory Syncytial Virus
|
- |
|
Resistance Gene: CTX-M
|
- |
|
Resistance Gene: IMP
|
- |
|
Resistance Gene: KPC
|
- |
|
Resistance Gene: mecA/C & MREJ
|
- |
|
Resistance Gene: NDM
|
- |
|
Resistance Gene: OXA-48
|
- |
|
Resistance Gene: VIM
|
- |
| Simulated serum- NEW 2021 |
Chemistry analytes (in alphabetical order)
|
- |
|
ACE (Angiotensin-Converting-Enzyme)
|
- |
|
Acid Phosphatase
|
- |
|
Albumin, total
|
- |
|
Alkaline Phosphatase (ALP)
|
- |
|
ALT
|
- |
|
Amylase
|
- |
|
AST
|
- |
|
Bicarbonate
|
- |
|
Bile Acids
|
- |
|
Bilirubin indirect & total
|
- |
|
Calcium, ionized & total
|
- |
|
Chloride
|
- |
|
Cholesterol (total)
|
- |
|
Cholinesterase
|
- |
|
Copper
|
- |
|
Creatine Kinase (CK)
|
- |
|
Creatinine
|
- |
|
D-3-Hydroxybutyrate
|
- |
|
Fructosamine
|
- |
|
GGT
|
- |
|
GLDH
|
- |
|
Glucose
|
- |
|
HBDH
|
- |
|
Iron
|
- |
|
Lactate
|
- |
|
LDH
|
- |
|
Lipase
|
- |
|
Magnesium
|
- |
|
NEFA
|
- |
|
Osmolality
|
- |
|
Phosphate
|
- |
|
Potassium
|
- |
|
Protein (Total)
|
- |
|
Sodium
|
- |
|
T Uptake
|
- |
|
T3 Free
|
- |
|
T4 Free
|
- |
|
Thyroxine (T4)
|
- |
|
TIBC
|
measured or iron-based calculation |
|
Triglycerides
|
- |
|
Triiodothyronine (T3)
|
- |
|
TSH
|
- |
|
UIBC
|
- |
|
Urate
|
- |
|
Urea
|
- |
|
Zinc
|
- |
|
TDM Analytes
|
- |
|
Amikacin
|
- |
|
Carbamazepine
|
- |
|
Digoxin
|
- |
|
Gentamicin
|
- |
|
Lithium
|
- |
|
Paracetamol (Acetaminophen)
|
- |
|
Phenobarbital
|
- |
|
Phenytoin
|
- |
|
Salicylic acid
|
- |
|
Theophyline
|
- |
|
Tobramycin
|
- |
|
Valproate
|
- |
|
Vancomycin
|
- |
|
Immunoassay analytes
|
- |
|
11-deoxycortisol
|
- |
|
17-OH-Progesterone
|
- |
|
Aldosterone
|
- |
|
Alpha-Fetoprotein (AFP)
|
- |
|
Androstenedione
|
- |
|
CEA
|
- |
|
Cortisol
|
- |
|
DHEA Sulfate & unconjugated
|
- |
|
Ferritin (FER)
|
- |
|
Folate
|
- |
|
Follicle Stimulating Hormone (FSH)
|
- |
|
Growth Hormone (hGH)
|
- |
|
hCG
|
- |
|
LH
|
- |
|
Oestradiol
|
- |
|
Oestriol free & total
|
- |
|
PAP
|
- |
|
Prealbumin
|
- |
|
Progesterone
|
- |
|
Prolactin
|
- |
|
PSA Total
|
- |
|
SHBG
|
- |
|
Testosterone, Free & Total
|
- |
|
TIBC
|
- |
|
Thyroxin Binding Globulin (TBG)
|
- |
|
Transferrin
|
- |
|
Vitamin B12
|
- |
| Serum (ALM)- NEW 2021 |
Acetone
|
- |
|
Ethanol
|
- |
|
Ammonia
|
- |
| (BLG) Blood gas- NEW 2021 |
pCO2, pH, pO2, potassium, sodium, urea, pre- and/or post-analytical indicators
|
- |
|
Calcium, ionized
|
- |
|
Creatinine
|
- |
|
Glucose
|
- |
|
Lactate
|
- |
|
Magnesium
|
- |
| Blood oximetry (haemoglobin from bovine)- NEW 2021 |
Carboxyhaemoglobin
|
- |
|
Haematocrit
|
- |
|
Haemoglobin, total
|
- |
|
Methaemoglobin
|
- |
|
Oxyhaemoglobin
|
- |
|
Magnesium
|
- |
| Cardiac markers (CAR) - lyophilised serum- NEW 2021 |
BNP
|
- |
|
CK-MB (Activity & mass)
|
- |
|
Creatine Kinase (CK), total
|
- |
|
D Dimer
|
- |
|
Homocysteine
|
- |
|
Myoglobin
|
- |
|
NT-pro BNP
|
- |
|
Troponin I
|
- |
|
Troponin T
|
- |
| Glycosylated haemoglobin (GLH) - lyophilised haemolysed human blood- NEW 2021 |
Glycated Haemoglobin (HbA1c)
|
- |
| Sedimetation rate- simulated whole blood- NEW 2021 |
Sedimentation rate
|
- |
| Neonatal bilirubin (NB) - serum- NEW 2021 |
Bilirubin, direct & total
|
- |
| Immunoassay- Special - lyophilised serum- NEW 2021 |
Vitamin D3 (25 Hydroxy Vitamin D)
|
- |
|
1-25-hydroxy Vitamin D3
|
- |
|
ACTH
|
- |
|
Calcitonin
|
- |
|
G-peptide
|
- |
|
Gastrin
|
- |
|
IGF-1
|
- |
|
Insulin
|
- |
|
Osteocalcin
|
- |
|
Parathyroid Hormone (PTH)
|
- |
|
Plasma renin activity
|
- |
|
Procalcitonin
|
- |
|
Renin (direct concentration)
|
- |
| Simulated sputum samples with chemically modified, non-infectious bacterial cells |
Mycobacterium tuberculosis complex
|
- |
|
Rifampin resistance
|
- |
| Simulated patient samples from various sources containing mycobacteria in liquid samples and/or lyophilized on loops |
Mycobacteriology culture ID
|
Culture isolation and identification |
| Simulated patient cultures containing fungus, yeast and aerobic actinomycetes lyophilized on swab |
Mycology culture ID
|
Culture isolation and identification |
| Giemsa stained thick and/or thin patient blood smears containing various blood parasites |
Blood parasite ID
|
Microscopic identification |
| Spinal fluid - simulated CSF- NEW 2021 |
Albumin
|
- |
|
Chloride
|
- |
|
Glucose
|
- |
|
Ig G
|
- |
|
Lactate
|
- |
|
LDH
|
- |
|
Potassium
|
- |
|
Sodium
|
- |
|
Total Protein
|
- |
| Tumour markers - lyophilised serum- NEW 2021 |
Beta 2 microglobulin
|
- |
|
CA 125
|
- |
|
CA 15-3
|
- |
|
CA 19-9
|
- |
|
CA 27-29
|
- |
|
NSE
|
- |
|
PSA Free
|
- |
|
Thyroglobulin
|
- |
| Urine chemistry - urine- NEW 2021 |
Albumin
|
- |
|
Albumin, creatinine, albumin-creatinine ratio
|
- |
|
Amylase
|
- |
|
Calcium
|
- |
|
Chloride
|
- |
|
Creatinine
|
- |
|
Glucose
|
- |
|
Magnesium
|
- |
|
Microalbumin
|
- |
|
Osmolality
|
- |
|
Phosphate
|
- |
|
Potassium
|
- |
|
Sodium
|
- |
|
Nitrogen, Total
|
- |
|
Urate
|
- |
|
Urea
|
- |
|
Total Protein
|
- |
| Blood cell ID-advanced & differential- Annotated cells/objects on a virtual slide- NEW 2021 |
Blood cell Identification
|
- |
|
Neutrophils, segmented or band
|
- |
|
Lymphocytes
|
- |
|
Monocytes
|
- |
|
Basophils
|
- |
|
Eosinophils
|
- |
|
Lymphocytes, reactive
|
- |
|
Immature cells
|
- |
|
NRBC - Nucleated Red Blood Cell Count
|
- |
|
Platelet estimate
|
- |
|
Unclassified cells
|
- |
| Basic haematology- simulated whole blood- NEW 2021 |
Haematocrit (HCT)
|
- |
|
Haemoglobin
|
- |
|
MCH
|
- |
|
MCHC
|
- |
|
MCV
|
- |
|
MPV - Mean Platelet Volume
|
- |
|
Platelet
|
- |
|
Plateletcrit
|
- |
|
RBC
|
- |
|
RDW-CV
|
- |
|
RDW-SD
|
- |
|
WBC
|
- |
| 5 Part Diff CBCX- simulated whole blood- NEW 2021 |
Haematocrit (HCT)
|
- |
|
Haemoglobin
|
- |
|
MCH
|
- |
|
MCHC
|
- |
|
MCV
|
- |
|
MPV - Mean Platelet Volume
|
- |
|
Platelet
|
- |
|
RBC
|
- |
|
RDW-CV
|
- |
|
RDW-SD
|
- |
|
WBC
|
- |
|
Neutrophils
|
- |
|
Lymphocytes, including absolute
|
- |
|
Monocytes
|
- |
|
Eosinophils, neutrophils, basophils (absolute)
|
- |
|
Immature Granulocytes, absolute
|
- |
|
Nucleated RCBs
|
- |
| Coagulation -lyophilised plasma- NEW 2021 |
APTT - Activated partial thromboplastin time
|
- |
|
Fibrinogen
|
- |
|
INR/PT
|
- |
|
Prothrombin time (PT)
|
- |
|
Thrombin Time (TT)
|
- |
|
Antithrombin III Activity (AT III)
|
- |
|
Factor II, V, VII, VIII, IX, X, XI, XII activity
|
- |
|
Plasminogen activity
|
- |
|
Protein C Activity
|
- |
|
Protein S activity
|
- |
| Microscopy package- virtual images- NEW 2021 |
Fecal WBC
|
- |
|
Fern test
|
- |
|
Nasal smear
|
- |
|
Pinworm prep
|
- |
|
Sperm
|
- |
|
Urine Sediment
|
- |
|
Vaginal wet prep & KOH
|
- |
| Urinalysis and HCG - Urine- NEW 2021 |
Bilirrubin & bilirubin confirmatory
|
- |
|
Blood (haemoglobin)
|
- |
|
Creatinine
|
- |
|
Glucose
|
- |
|
HCG (total)
|
- |
|
Ketones
|
- |
|
Leukocyte esterase
|
- |
|
Nitrite
|
- |
|
pH
|
- |
|
Protein, total & confirmatory
|
- |
|
Reducing substances
|
- |
|
Urobilinogen
|
- |
|
Specific Gravity
|
- |
| Hepatitis serology- serum- NEW 2021 |
Anti-HAV, total, IgG, IgM
|
- |
|
Anti-HBc, IgG, IgM
|
- |
|
Anti-HBs
|
- |
|
Anti-HCV
|
- |
|
HBsAg
|
- |
| Immunoproteins/ C3 and C4- lyophilised serum- NEW 2021 |
Alpha 1 Acid Glycoprotein
|
- |
|
Alpha 1 Antitrypsin
|
- |
|
Alpha-2-macroglobulin
|
- |
|
Anti-streptolysin O
|
- |
|
Antithrombin III (AT III)
|
- |
|
Ceruloplasmine
|
- |
|
Complement C3, C4
|
- |
|
C -Reactive Protein
|
- |
|
Haptoglobin
|
- |
|
IgA, IgG and IgM
|
- |
|
Kappa light chains, total & free
|
- |
|
Lambda chain, total & free
|
- |
|
Retinol Binding Protein
|
- |
|
Rheumatoid Factor
|
- |
| HIV serology- serum- NEW 2021 |
Anti-HI-1, 1, 1/2
|
- |
|
HIV-1 p24 Antigen
|
- |
| Rubella- serum- NEW 2021 |
Rubella IgG, IgM
|
- |
| Syphilis- serum- NEW 2021 |
Syphilis
|
- |
| Thyroid antibodies- serum- NEW 2021 |
Anti-TG
|
- |
|
Anti-TPO
|
- |
| High sensitivity CRP- serum- NEW 2021 |
C-Reactive Protein (CRP)
|
- |
|
hs
|
- |
| Basic bacteriology package- lyophilised swabs- NEW 2021 |
IMP
|
- |
|
KPC
|
- |
|
NDM
|
- |
|
OXA-48
|
- |
|
VIM
|
- |
| Mycoplasma genitalium (molecular)- liquid samples- NEW 2021 |
Mycoplasma genitalium
|
- |
| Norovirus -molecular - NEW 2021 |
Norovirus GI/GII
|
- |
| Carbapenem-Resistant Organisms- lyophilised swabs and/or lyophilised pellet in vials with diluent- NEW 2021 |
Blood culture susceptibility & identification
|
- |
|
Throat culture ID
|
- |
|
Urine colony count, identification & susceptibility
|
- |
| Infectious mononucleosis- serum -NEW 2021 |
Infectious mononucleosis
|
- |
| Simulated patient samples containing lyophilized bacteria on a swab. |
Vancomycin-Resistant Enterococcus
|
Molecular |
| Formalin fixed bacterial and/or mycobacterial organisms dried on a glass slide |
Acid Fast Bacilli Smear
|
- |
| Whole blood and packed red cells |
ABO Group
|
- |
|
ABO Subgroup
|
- |
|
D (Rho) type
|
- |
|
Antibody Screen/Identification
|
- |
|
Antigen typing
|
- |
|
Compatibility testing
|
- |
|
Direct Anti-globulin Testing (DAT)
|
- |
